Sedana Medical Logo

Sedana Medical

Develops inhaled sedation therapies for mechanically ventilated patients in intensive care.

SEDANA | ST

Overview

Corporate Details

ISIN(s):
SE0015988373
LEI:
549300FQ3NJRI56LCX32
Country:
Sweden
Address:
Svärdvägen 3A, 182 33 DANDERYD

Description

Sedana Medical is a medical technology and pharmaceutical company specializing in inhaled sedation for mechanically ventilated patients in intensive care. The company develops, manufactures, and markets medical devices and pharmaceuticals, including its primary product, the AnaConDa (Anaesthetic Conserving Device). This system is designed for the administration of volatile anesthetics in intensive care units. The company's mission is to establish inhaled sedation as a standard therapy, aiming to improve patient outcomes and quality of life during and after the sedation period.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-04-17 12:12 Swedish 14.2 KB
2025-04-15 08:00
Notice of Annual General Meeting in Sedana Medical
English 138.7 KB
2025-04-15 08:00
Sedana Medical kallar till årsstämma
Swedish 135.7 KB
2025-04-10 17:32 Swedish 11.9 MB
2025-02-13 07:01 Swedish 1.2 MB
2025-02-13 07:01 English 1.0 MB
2025-02-12 17:30
Sedana Medical announces positive high-level results also for its second pivota…
English 110.3 KB
2025-02-12 17:30
Sedana Medical meddelar positiva topline-resultat även för bolagets andra pivot…
Swedish 110.8 KB
2025-02-03 17:30
Sedana Medical erhåller ytterligare ett års marknadsskydd för Sedaconda® (isofl…
Swedish 108.1 KB
2025-02-03 17:30
Sedana Medical receives an additional year of market protection for Sedaconda® …
English 107.5 KB
2024-12-19 19:59
Sedana Medical announces positive high-level results of its first pivotal trial…
English 108.3 KB
2024-12-19 19:59
Sedana Medical meddelar positiva topline-resultat från bolagets första pivotala…
Swedish 108.6 KB
2024-12-13 17:35
Sedana Medical erhåller positivt besked att inkludera barn (3-17 år) i indikati…
Swedish 109.8 KB
2024-12-13 17:35
Sedana Medical receives a positive decision to include children (3-17 years) in…
English 108.9 KB
2024-11-29 15:00
Sedana Medical slutför förvärv av huvudleverantör
Swedish 105.5 KB

Automate Your Workflow. Get a real-time feed of all Sedana Medical filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sedana Medical

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sedana Medical via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-18 Christoffer Björn Rosenblad Other Buy 10,000 101,000.00 SEK
2024-11-04 Claus Bjerre Other Buy 125,000 1,475,000.00 SEK
2022-08-29 Christoffer Björn Rosenblad Other Buy 10,000 232,000.00 SEK
2022-08-29 Christoffer Björn Rosenblad Other Sell 5,000 115,000.00 SEK
2022-07-21 Hilde Furberg Other Buy 3,000 64,288.44 SEK
2022-04-28 Johan Spetz Other Buy 6,461 223,615.21 SEK
2022-04-28 Johannes Doll Other Buy 6,000 209,520.60 SEK
2022-04-28 Christoffer Björn Rosenblad Other Buy 5,000 161,400.00 SEK
2021-12-03 Johannes Doll Other Buy 11,630 1,000,180.00 SEK
2021-09-20 Ola Gunnar Magnusson Other Sell 30,000 2,943,000.00 SEK

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.